Results 61 to 70 of about 526 (116)
Summary Background: Solar urticaria is a rare photosensitivity disorder demonstrating a range of action spectra, which can inflict a very large impact on life quality despite available treatments.
A.K. Haylett +10 more
core +1 more source
Melanocortin receptors in GtoPdb v.2025.3 [PDF]
Melanocortin receptors (provisional nomenclature as recommended by NC-IUPHAR [41]) are activated by members of the melanocortin family (α-MSH, β-MSH and γ-MSH forms; δ form is not found in mammals) and adrenocorticotrophin (ACTH ...
Gantz, Ira +14 more
core +1 more source
Current challenges in photoprotection
Electromagnetic radiation in the ultraviolet, visible, and infrared ranges all produce biologic effects. Ultraviolet filters are the most well-studied photoprotective measure for the adverse effects of ultraviolet radiation.
Stengel, Fernando +2 more
core +1 more source
Melanotropic peptides: More than just 'Barbie drugs' and 'sun-tan jabs'?
While ultraviolet radiation (UVR) is a major cause of skin ageing and carcinogenesis, public pursuit of a novel tanning strategy circumventing the need for UVR is increasingly reported in the media and scientific press.
Langan, E. A. +5 more
core +1 more source
Acute impact of afamelanotide on UVR erythemal and melanogenic responses in healthy humans in vivo: an exploratory study. [PDF]
Griffin LL +5 more
europepmc +1 more source
Toward sustainable solid-phase peptide synthesis strategy – in situ Fmoc removal
Solid-phase peptide synthesis (SPPS) is the method of choice for the synthesis of peptides for research and production purposes. Despite having several positive features, it remains a challenge to reduce the amount of solvent waste generated during the ...
Ashish Kumar (152984) +5 more
core +1 more source
Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates. [PDF]
Park M +11 more
europepmc +1 more source
FDA approved drug containing acetamide group- a mini review. [PDF]
Bindra S +7 more
europepmc +1 more source
Current trials in erythropoietic protoporphyria: are placebo controls ethical? [PDF]
Barman-Aksözen J +2 more
europepmc +1 more source
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria. [PDF]
Madigan KE +4 more
europepmc +1 more source

